259.3 ð©º å §ç§å°ç§èåç
259.3.0.1 1ïžâ£ STEMI Inferior + RV Workup
- Inferior STEMI (II, III, aVF) â always check V4R for RV infarct
- RV infarct: hypotension with NTG â IV fluids essential (donât use NTG-related vasodilators if RV infarct)
- Bezold-Jarisch reflex: bradycardia + hypotension
259.3.0.2 2ïžâ£ Sgarbossa Modified Criteria
- Updated 2012 â more sensitive
- ST/S ratio: discordant ST elevation / S wave depth ⥠0.25 â diagnostic
- Better for diagnosing MI in setting of LBBB
259.3.0.3 3ïžâ£ AI-ECG Advances 2024
- LVEF estimation from 12-lead ECG (Mayo Clinic; FDA approved)
- AF prediction from sinus rhythm ECG
- Hyperkalemia detection from ECG patterns
- Improving accuracy + integration in clinical workflow
- Caveat: validation in diverse populations ongoing
259.3.0.4 4ïžâ£ Long QT Drug Considerations
- Liverpool QT Drug Interaction Database for review
- High-risk drugs in combination: avoid or monitor
- Methadone particularly QT-prolonging
- Combination of QT prolongers + electrolyte abnormalities (especially hypokalemia) â high torsades risk
259.3.0.5 5ïžâ£ Brugada Syndrome
- Type 1 (coved) â diagnostic + risk SCD
- Type 2 (saddle-back) â suggestive; confirm with provocative test (procainamide, ajmaline, flecainide IV)
- Genetic testing (SCN5A) for first-degree relatives
- ICD for symptomatic or high-risk
259.3.0.6 6ïžâ£ Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
- Epsilon wave (small upstroke in V1)
- T-wave inversion V1-V3 (not in BBB)
- Family history of SCD
- MRI for diagnosis
- ICD for high-risk
259.3.0.7 7ïžâ£ å¥ä¿ / Taiwan
- 12-lead ECG widely available
- AI-ECG implementation å¢å (recent tertiary centers)
- å¥ä¿ covers ECG for indication
- Cardiology + electrophysiology referrals
259.3.0.8 8ïžâ£ Ambulatory ECG Monitoring
- Holter (24-48 hr): for symptomatic intermittent
- Event monitor (14-30 d): for less frequent
- Implantable loop recorder (ILR): for rare / recurrent unexplained syncope
- Wearables (Apple Watch, Fitbit): increasing role in AF detection
- Mobile ECG devices (KardiaMobile): patient-driven